−0.0002 USD
−67.73 K USD
310.89 K USD
67.71 M
About Global Pharmatech, Inc.
Sector
Industry
CEO
Melson Liao
Headquarters
Hong Kong
Founded
2001
FIGI
BBG000DZG4H3
Global Pharmatech, Inc. engages in the discovery, development, manufacture, and marketing of proprietary drugs developed based on traditional Chinese medicine. The company was founded on June 26, 2001 and is headquartered in Hong Kong, China.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of GBLP is 0.2420 USD — it has decreased by −13.53% in the past 24 hours. Watch Global Pharmatech, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Global Pharmatech, Inc. stocks are traded under the ticker GBLP.
GBLP stock has fallen by −3.22% compared to the previous week, the month change is a 58.71% rise, over the last year Global Pharmatech, Inc. has showed a 61.36% increase.
GBLP reached its all-time high on May 29, 2002 with the price of 700.0000 USD, and its all-time low was 0.0080 USD and was reached on Nov 12, 2019. View more price dynamics on GBLP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GBLP stock is 15.64% volatile and has beta coefficient of −0.20. Track Global Pharmatech, Inc. stock price on the chart and check out the list of the most volatile stocks — is Global Pharmatech, Inc. there?
Today Global Pharmatech, Inc. has the market capitalization of 116.22 M, it has decreased by −90.27% over the last week.
Yes, you can track Global Pharmatech, Inc. financials in yearly and quarterly reports right on TradingView.
GBLP net income for the last quarter is −24.72 K USD, while the quarter before that showed −469.00 USD of net income which accounts for −5.17 K% change. Track more Global Pharmatech, Inc. financial stats to get the full picture.
No, GBLP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Global Pharmatech, Inc. EBITDA is −60.63 K USD, and current EBITDA margin is −19.50%. See more stats in Global Pharmatech, Inc. financial statements.
Like other stocks, GBLP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Global Pharmatech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Global Pharmatech, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Global Pharmatech, Inc. stock shows the buy signal. See more of Global Pharmatech, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.